Valuation Update With 7 Day Price Move • Aug 13
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to NT$7.01, the stock trades at a trailing P/E ratio of 37.7x. Average trailing P/E is 25x in the Chemicals industry in Taiwan. Total returns to shareholders of 23% over the past three years. Valuation Update With 7 Day Price Move • Jul 30
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to NT$5.52, the stock trades at a trailing P/E ratio of 29.7x. Average trailing P/E is 25x in the Chemicals industry in Taiwan. Total loss to shareholders of 7.2% over the past three years. Valuation Update With 7 Day Price Move • Jun 30
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to NT$6.71, the stock trades at a trailing P/E ratio of 36.1x. Average trailing P/E is 32x in the Chemicals industry in Taiwan. Total returns to shareholders of 6.5% over the past three years. Valuation Update With 7 Day Price Move • Jun 11
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to NT$7.41, the stock trades at a trailing P/E ratio of 39.8x. Average trailing P/E is 31x in the Chemicals industry in Taiwan. Total returns to shareholders of 13% over the past three years. Valuation Update With 7 Day Price Move • May 20
Investor sentiment deteriorates as stock falls 22% After last week's 22% share price decline to NT$7.85, the stock trades at a trailing P/E ratio of 42.2x. Average trailing P/E is 30x in the Chemicals industry in Taiwan. Total returns to shareholders of 26% over the past three years. Valuation Update With 7 Day Price Move • Apr 29
Investor sentiment deteriorates as stock falls 39% After last week's 39% share price decline to NT$11.20, the stock trades at a trailing P/E ratio of 60.2x. Average trailing P/E is 31x in the Chemicals industry in Taiwan. Total returns to shareholders of 82% over the past three years. Reported Earnings • Apr 23
Full year 2025 earnings released: EPS: NT$0.19 (vs NT$0.077 in FY 2024) Full year 2025 results: EPS: NT$0.19 (up from NT$0.077 in FY 2024). Revenue: NT$333.5m (up 13% from FY 2024). Net income: NT$14.4m (up 143% from FY 2024). Profit margin: 4.3% (up from 2.0% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 39% per year whereas the company’s share price has increased by 35% per year. Buy Or Sell Opportunity • Apr 21
Now 21% overvalued after recent price rise Over the last 90 days, the stock has risen 130% to NT$13.80. The fair value is estimated to be NT$11.41, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 2.9% over the last 3 years. Earnings per share has grown by 30%. Valuation Update With 7 Day Price Move • Apr 15
Investor sentiment improves as stock rises 32% After last week's 32% share price gain to NT$7.15, the stock trades at a trailing P/E ratio of 54.2x. Average trailing P/E is 29x in the Chemicals industry in Taiwan. Total returns to shareholders of 14% over the past three years. Valuation Update With 7 Day Price Move • Mar 25
Investor sentiment improves as stock rises 28% After last week's 28% share price gain to NT$6.67, the stock trades at a trailing P/E ratio of 50.6x. Average trailing P/E is 27x in the Chemicals industry in Taiwan. Total loss to shareholders of 1.6% over the past three years. Announcement • Mar 06
Tatung Fine Chemicals Co., Annual General Meeting, Jun 26, 2026 Tatung Fine Chemicals Co., Annual General Meeting, Jun 26, 2026. Location: no,247-1, guanyin district, taoyuan city Taiwan Valuation Update With 7 Day Price Move • Mar 06
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to NT$5.46, the stock trades at a trailing P/E ratio of 41.4x. Average trailing P/E is 23x in the Chemicals industry in Taiwan. Total loss to shareholders of 14% over the past three years. New Risk • Feb 28
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (30% average weekly change). Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Market cap is less than US$100m (NT$523.8m market cap, or US$16.7m). Buy Or Sell Opportunity • Jan 28
Now 32% overvalued after recent price rise Over the last 90 days, the stock has risen 129% to NT$14.50. The fair value is estimated to be NT$10.96, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 2.9% over the last 3 years. Earnings per share has grown by 30%. New Risk • Jan 27
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 7.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.2% average weekly change). Market cap is less than US$100m (NT$611.5m market cap, or US$19.4m). Valuation Update With 7 Day Price Move • Jan 27
Investor sentiment improves as stock rises 29% After last week's 29% share price gain to NT$7.88, the stock trades at a trailing P/E ratio of 59.8x. Average trailing P/E is 23x in the Chemicals industry in Taiwan. Total returns to shareholders of 44% over the past three years. Valuation Update With 7 Day Price Move • Sep 10
Investor sentiment improves as stock rises 22% After last week's 22% share price gain to NT$7.50, the stock trades at a trailing P/E ratio of 56.9x. Average trailing P/E is 26x in the Chemicals industry in Taiwan. Total returns to shareholders of 17% over the past three years. Valuation Update With 7 Day Price Move • Aug 19
Investor sentiment improves as stock rises 24% After last week's 24% share price gain to NT$6.45, the stock trades at a trailing P/E ratio of 48.9x. Average trailing P/E is 25x in the Chemicals industry in Taiwan. Total returns to shareholders of 8.4% over the past three years. New Risk • Aug 18
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Taiwanese stocks, typically moving 9.9% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (9.9% average weekly change). Minor Risk Market cap is less than US$100m (NT$557.1m market cap, or US$18.5m). New Risk • Apr 10
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 8.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.3% average weekly change). Market cap is less than US$100m (NT$450.1m market cap, or US$13.7m). Valuation Update With 7 Day Price Move • Apr 09
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to NT$5.10, the stock trades at a trailing P/E ratio of 66.5x. Average trailing P/E is 17x in the Chemicals industry in Taiwan. Total loss to shareholders of 30% over the past three years. Reported Earnings • Apr 04
Full year 2024 earnings released: EPS: NT$0.08 (vs NT$0.056 in FY 2023) Full year 2024 results: EPS: NT$0.08 (up from NT$0.056 in FY 2023). Revenue: NT$295.2m (up 13% from FY 2023). Net income: NT$5.95m (up 38% from FY 2023). Profit margin: 2.0% (up from 1.7% in FY 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings. New Risk • Feb 28
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Market cap is less than US$100m (NT$483.4m market cap, or US$14.7m). Announcement • Feb 27
Tatung Fine Chemicals Co., Annual General Meeting, Jun 25, 2025 Tatung Fine Chemicals Co., Annual General Meeting, Jun 25, 2025. Location: no,247-1, guanyin district, taoyuan city Taiwan New Risk • Nov 07
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.6% average weekly change). Market cap is less than US$100m (NT$530.0m market cap, or US$16.4m). New Risk • Apr 09
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 37% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (NT$526.9m market cap, or US$16.4m). Announcement • Mar 27
Tatung Fine Chemicals Co., Annual General Meeting, Jun 26, 2024 Tatung Fine Chemicals Co., Annual General Meeting, Jun 26, 2024. New Risk • Feb 26
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Market cap is less than US$100m (NT$557.9m market cap, or US$17.6m). New Risk • Oct 06
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.1% average weekly change). Market cap is less than US$100m (NT$631.6m market cap, or US$19.6m). Board Change • Nov 16
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 10 experienced directors. No highly experienced directors. 4 independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Jul 04
Investor sentiment deteriorated over the past week After last week's 16% share price decline to NT$5.19, the stock trades at a trailing P/E ratio of 75x. Average trailing P/E is 14x in the Chemicals industry in Taiwan. Total returns to shareholders of 92% over the past three years. Valuation Update With 7 Day Price Move • May 09
Investor sentiment deteriorated over the past week After last week's 18% share price decline to NT$5.40, the stock trades at a trailing P/E ratio of 78.1x. Average trailing P/E is 17x in the Chemicals industry in Taiwan. Total returns to shareholders of 138% over the past three years. Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 10 experienced directors. No highly experienced directors. 4 independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • Apr 18
Full year 2021 earnings released: EPS: NT$0.07 (vs NT$0.20 loss in FY 2020) Full year 2021 results: EPS: NT$0.07 (up from NT$0.20 loss in FY 2020). Revenue: NT$300.5m (up 25% from FY 2020). Net income: NT$5.37m (up NT$20.9m from FY 2020). Profit margin: 1.8% (up from net loss in FY 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 127% per year but the company’s share price has only increased by 38% per year, which means it is significantly lagging earnings growth. Reported Earnings • Aug 18
First half 2021 earnings released: EPS NT$0.10 (vs NT$0.16 loss in 1H 2020) The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: NT$150.8m (up 43% from 1H 2020). Net income: NT$7.40m (up NT$19.7m from 1H 2020). Profit margin: 4.9% (up from net loss in 1H 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 99% per year but the company’s share price has only increased by 29% per year, which means it is significantly lagging earnings growth. Reported Earnings • Mar 30
Full year 2020 earnings released: NT$0.20 loss per share (vs NT$0.013 profit in FY 2019) The company reported a poor full year result with weaker earnings, revenues and control over costs. Full year 2020 results: Revenue: NT$239.5m (down 7.4% from FY 2019). Net loss: NT$15.6m (down NT$16.6m from profit in FY 2019). Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has only increased by 19% per year, which means it is significantly lagging earnings growth. Is New 90 Day High Low • Feb 23
New 90-day high: NT$9.00 The company is up 226% from its price of NT$2.76 on 25 November 2020. The Taiwanese market is up 18% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 8.0% over the same period. Is New 90 Day High Low • Feb 02
New 90-day high: NT$8.30 The company is up 202% from its price of NT$2.75 on 05 November 2020. The Taiwanese market is up 19% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 7.0% over the same period. Is New 90 Day High Low • Jan 14
New 90-day high: NT$5.04 The company is up 80% from its price of NT$2.80 on 16 October 2020. The Taiwanese market is up 22% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 20% over the same period. Is New 90 Day High Low • Dec 04
New 90-day high: NT$3.14 The company is up 3.0% from its price of NT$3.05 on 04 September 2020. The Taiwanese market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period. 
